These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin. Okumura N, Haneishi A, Terasawa F. Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936 [Abstract] [Full Text] [Related]
7. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen. Damgaard D, Senolt L, Nielsen MF, Pruijn GJ, Nielsen CH. Arthritis Res Ther; 2014 Dec 05; 16(6):498. PubMed ID: 25475141 [Abstract] [Full Text] [Related]
10. Citrullinated fibrinogen forms densely packed clots with decreased permeability. Varjú I, Tóth E, Farkas ÁZ, Farkas VJ, Komorowicz E, Feller T, Kiss B, Kellermayer MZ, Szabó L, Wacha A, Bóta A, Longstaff C, Kolev K. J Thromb Haemost; 2022 Dec 05; 20(12):2862-2872. PubMed ID: 36083779 [Abstract] [Full Text] [Related]
11. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation. Bawadekar M, Shim D, Johnson CJ, Warner TF, Rebernick R, Damgaard D, Nielsen CH, Pruijn GJM, Nett JE, Shelef MA. J Autoimmun; 2017 Jun 05; 80():39-47. PubMed ID: 28188029 [Abstract] [Full Text] [Related]